Intelligence / Healthtech / FDA 510(k) Clearances / I-Sens, Inc.
Approvalsdevice cleared2 Oct 2026
I-Sens, Inc.
2 Oct 2026: Device cleared · CVS Advanced PLUS Blood Glucose Monitoring System. Recorded in the openFDA device 510(k) data.
- Decided
- 2 Oct 2026
- Device
- CVS Advanced PLUS Blood Glucose Monitoring System
- Specialty
- Clinical Chemistry
- Country
- South Korea
- Location
- Seoul
- Clearance type
- Special
- 510(k) number
- K260689
- Submitted
- 2026-03-03
What this signal means
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS
Find the decision makers at I-Sens, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Clinical Chemistry
FDA 510(k) Clearances
6 NovSiemens Healthcare Diagnostics, Inc.device cleared · Atellica IM Vitamin D Total II (VitDII)Approvals30 OctChangsha Sinocare, Inc.device cleared · Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring SystemApprovals28 OctCMT Health PTE., Ltd.device cleared · Profoject Safe Push Button Blood Collection SetsApprovals23 OctEPS Bio Technology Corp.device cleared · EASYMAX Voice Blood Glucose Monitoring SystemApprovals21 OctBeta Bionics, Inc.device cleared · Mint ACE PumpApprovals21 OctSol-Millennium Medical, Inc.device cleared · Sol-Guard Safety Pull Button Collection Set; Sol-Guard XtraThin Safety Pull-Button Blood Collection SetApprovals
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.